Canopy Growth Corp (NASDAQ:CGC) Share Price

Company Profile

Business description
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.
Contact
1 Hershey Drive
Smiths FallsONK7A 0A8
CAN
T: +1 855 558-9333
https://www.canopygrowth.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2027
Employees
1,128

Recommended

Companies with US exposure are better positioned to benefit from easing prohibition, writes Kristoffer Inton.

Kristoffer Inton | 26 October 2020

Morningstar thinks these companies are well positioned to benefit from one of five key trends during the next decade, writes Susan Dziubinski.

Susan Dziubinski | 01 October 2020

In ten years’ time, you won’t be illegally smoking cannabis, you’ll be legally eating it. Here are some stocks to watch.

Lex Hall | 22 September 2020

Index	Last price	Change	% Change
All Ordinaries	8,937.00	59.30	0.67%
CAC 40	7,832.88	29.55	0.38%
DAX 40	25,277.68	190.41	0.76%
Dow JONES (US)	51,850.55	195.60	0.38%
FTSE 100	10,656.28	104.23	0.99%
HKSE	24,271.20	59.85	0.25%
NASDAQ	27,245.90	120.27	-0.44%
Nikkei 225	69,030.92	11.19	-0.02%
NZX 50 Index	13,775.71	51.91	-0.38%
S&P 500	7,807.24	4.30	-0.06%
S&P/ASX 200	8,783.20	66.60	0.76%
SSE Composite Index	3,797.24	16.55	-0.43%